|
|
PLoS ONE. 2007; 2(5): e462. Published online 2007 May 23. doi: 10.1371/journal.pone.0000462. | PMCID: PMC1866178 |
Copyright Lo et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Positive Selection within the Schizophrenia-Associated GABAA Receptor β2 Gene Wing-Sze Lo,#1 Zhiwen Xu,#1 Zhiliang Yu,#2 Frank W. Pun,#1 Siu-Kin Ng,3 Jianhuan Chen,1 Ka-Lok Tong,1 Cunyou Zhao,3 Xiaojing Xu,3 Shui-Ying Tsang,1 Mutsuo Harano,4 Gerald Stöber,5 Vishwajit L. Nimgaonkar,6 and Hong Xue1* 1Department of Biochemistry, Applied Genomics Laboratory and HKH Bioinformatics Center, Hong Kong University of Science and Technology, Clear Water Bay, Hong Kong, China 2Graduate program of Atmospheric, Marine, and Coastal Environment, Hong Kong University of Science and Technology, Clear Water Bay, Hong Kong, China 3Graduate Program of Bioengineering, Hong Kong University of Science and Technology, Clear Water Bay, Hong Kong, China 4Department of Neuropsychiatry, Kurume University School of Medicine, Fukuka, Japan 5Department of Psychiatry and Psychotherapy, University of Würzburg, Würzburg, Germany 6Departments of Psychiatry and Human Genetics, University of Pittsburgh School of Medicine, and Graduate School of Public Health, Pittsburgh, Pennsylvania, United States of America Emmanouil Dermitzakis, Academic Editor The Wellcome Trust Sanger Institute, United Kingdom Received January 15, 2007; Accepted April 24, 2007. The gamma-aminobutyric acid type-A (GABAA) receptor plays a major role in inhibitory neurotransmissions. Intronic SNPs and haplotypes in GABRB2, the gene for GABAA receptor β2 subunit, are associated with schizophrenia and correlated with the expression of two alternatively spliced β2 isoforms. In the present study, using chimpanzee as an ancestral reference, high frequencies were observed for the derived (D) alleles of the four SNPs rs6556547, rs187269, rs1816071 and rs1816072 in GABRB2, suggesting the occurrence of positive selection for these derived alleles. Coalescence-based simulation showed that the population frequency spectra and the frequencies of H56, the haplotype having all four D alleles, significantly deviated from neutral-evolution expectation in various demographic models. Haplotypes containing the derived allele of rs1816072 displayed significantly less diversity compared to haplotypes containing its ancestral allele, further supporting positive selection. The variations in DD-genotype frequencies in five human populations provided a snapshot of the evolutionary history, which suggested that the positive selections of the D alleles are recent and likely ongoing. The divergence between the DD-genotype profiles of schizophrenic and control samples pointed to the schizophrenia-relevance of positive selections, with the schizophrenic samples showing weakened selections compared to the controls. These DD-genotypes were previously found to increase the expression of β2, especially its long isoform. Electrophysiological analysis showed that this long β2 isoform favored by the positive selections is more sensitive than the short isoform to the inhibition of GABAA receptor function by energy depletion. These findings represent the first demonstration of positive selection in a schizophrenia-associated gene. Schizophrenia is one of the most debilitating mental disorders, afflicting peoples of all countries and cultures with about 1% lifetime risk [1]. Schizophrenics suffer perturbations in thought processes that manifest as hallucinations, delusions, disordered thinking, unusual speech or behavior, and social withdrawal. Schizophrenia tends to run in families with an estimated inheritability of 60–85% [2]. A feature of the disease is a prominent impairment in cognitive functions, especially language-related functions that are unique to mankind. Understanding the etiology of schizophrenia therefore not only paves the way to effective therapeutic treatment of the disease, but may also provide important insight into the nature of human cognition. Over the past several years, advances in genomics have made possible an initial delineation of the genetic mechanisms of schizophrenia. DNA sequence polymorphisms in a number of genes are found to be associated with the disease [3]. One of the strongest associations is that discovered by our laboratory in the single nucleotide polymorphisms (SNPs) and haplotypes in introns 8 and 9 of GABRB2 [4]. GABRB2 codes for the β 2 subunit of GABA A receptor, and is part of a cluster of genes on chromosome 5q34 for the GABA A receptor, the major inhibitory neurotransmitter-gated channel receptor family in the central nervous system (CNS) [5]. Our initial findings from Han Chinese have since been validated by additional samples from the Chinese [6], Portuguese [7], German [7]– [9] and Japanese [9] populations, although conflicting results from Japanese [10] and German [11] populations have also been reported. As in the case of most other genes underlying complex disorders, the schizophrenia-associated DNA sequence polymorphisms in GABRB2 are located in the non-coding regions, and therefore not immediately evident in their functional implications. However, recent studies in our laboratory demonstrated that the schizophrenia-associated DNA sequence polymorphisms in GABRB2 are correlated with under-expression in schizophrenic brains of two alternatively spliced forms of mRNA coding for two previously reported isoforms of β 2 subunit that differ in length by 38 amino acid residues including a potential Ser/Thr phosphorylation site [12]. The longer isoform was also found to be more prone than the shorter isoform toward current run-down induced by repetitive activation. This finding of a genotype-dependent electrophysiological alteration, establishing an explicit relationship between genotype and potential neuronal behavior, represents the first instance of such relationships identified among the schizophrenia-associated genes. A human-specific Alu insertion Based on available genomic sequences of humans and a number of primates, an evolutionary analysis was conducted in the present study comparing human and non-human primate sequences in the schizophrenia-associated GABRB2 region in order to detect any sequence signatures of human-lineage specific changes that could be indicative of natural selection and therefore functional significance. The non-human primate sequences homologous to the 3,551-bp genomic region of human GABRB2 were either experimentally obtained or retrieved from the database (see Methods) (). The comparison revealed a human specific 314-bp insertion within this otherwise highly conserved non-coding region of GABRB2 ( Figure S1). By sequence homology this human-specific insert belongs to the Yi6 sub-group of Alu ( Figure S2), a primate-specific family of short interspersed mobile elements with over one million members in the human genome [13]. This insert, which is not identical to any known Alu sequence, is named Yi6AH151 in accordance to Batzer's Alu nomenclature, thereby adding to the 150 known Alu Yi6 elements [14]. It is absent from the non-human primates, but present in all the human subjects analyzed. Therefore it likely represents an insertion into the human lineage prior to human population subdivisions, rather than a deletion from the chimpanzee lineage. That the two SNPs rs34820615 and rs10060148 in Yi6AH151 were found to be associated with schizophrenia [9] suggests the involvement of this Alu in schizophrenia etiology. Possible Alu involvements also have been reported for other diseases [15]. High sequence diversity in a conserved non-coding region Re-sequencing was performed on the 3,551-bp genomic segment in the neighborhood of Yi6AH151 for a total of 633 unrelated non-schizophrenic individuals of the four ethnically diverse human populations African (AF), German Caucasian (GE), USA Caucasian (US), and Japanese (JP). A total of 29 SNPs were identified, 15 in the 314-bp Alu Yi6AH151 and 14 on its flanking sequences. Using the chimpanzee and the Yi6 subfamily consensus sequences as references, the two alleles of each of the 29 SNPs could be determined as being the ancestral (N) or derived (D) allele ( and Table S1). Based on the N or D status defined, four of the twenty-nine SNPs were found to be exceptionally high in D-allele frequency (>50%), and designated as high-D SNPs ( and Table S1). Their high D-allele frequencies signaled the occurrence of positive selection. The four high-D SNPs are in descending order of D-allele frequencies rs6556547, rs187269, rs1816071 and rs1816072. Since rs1816072 exhibits the lowest D-allele frequency among them, it could represent the youngest of the four. The evolutionary divergences between species, and the diversities within the different human populations were scrutinized for any departure from neutrality. The 0.82% SNP density in the region was found to far exceed the genome-wide and locus-specific densities for the human genome (0.11–0.08%) [16]. Since this region falls within one of the recombination hotspots identified in the HapMap project ( Figure S3), the high SNP density observed might have originated from high recombination activities. In contrast, the 0.74% sequence mismatch between human and chimpanzee in the region is lower than the human genome average of 1.23% nucleotide divergence [17]. This cross-species conservation was suggestive of purifying selection, which is not unexpected for an exon-proximal genic region. This combination of low human-chimpanzee divergence and high intra-human diversity departs from the expectations of neutral evolution ( P = 0.0013 in the Hudson, Kreitman and Aguadé's test [18]), and points to the occurrence of human-specific events in this otherwise evolutionarily conserved non-coding region [19], [20], resulting in accelerated evolution within the human lineage. Ancestral and derived haplotype groups Frequency spectrum summary statistics were employed to test for any departure from neutral evolution in the region. Based on either the datasets pooled from all four populations, or the datasets of individual populations, positive selection was indicated by some demographic models in the Fay and Wu's H test, which takes the ancestral status of polymorphism sites into consideration and is sensitive to an excess of derived alleles. However, neither Tajima's D nor Fu and Li's D and F tests detected significant positive selection in the region ( Table S2). Accordingly, further investigations of potential positive selection were conducted on separate haplotype groups in accordance to Evans et al [21]. Using the allelic state of rs1816072, the youngest of the four high-D SNPs, as defining criterion, all the haplotypes containing its N allele were assigned to haplotype group-N (HG-N; 42.9%), and all those containing its D allele were assigned to haplotype group-D (HG-D; 57.1%) ( and Table S3). These HG-N and HG-D haplotype groups were sufficiently similar in size to allow statistically acceptable comparisons. HG-N and HG-D were vastly dissimilar with respect to sequence diversity. The haplotype ( Hd) and nucleotide (π) diversities of HG-D were much lower than those of HG-N ( Table S2). HG-N displayed a highly diversified membership of fifty different haplotypes (H1 to H50), all of relatively low frequencies ( and Table S3). H6, the most abundant member of this group, amounted to a frequency of only 8.5%. In contrast, HG-D contained only twenty-five member haplotypes (H51–H75). H56, its highest-frequency member comprising the D alleles of the four high-D SNPs together with the ancestral alleles of the other 25 SNP sites ( Table S3), was present in 51.7% of total N+D copies, or 90.5% of the D copies. This extraordinary predominance by a single haplotype confirmed to the occurrence of exceptionally strong positive selection for H56 and its four constituent D alleles. The differences between HG-N and HG-D in the Fay and Wu's H value populations were non-random for all three non-AF populations ( Table S2: GE and JP P<0.00001; US P= 0.07). The mutational spectra in the genealogies of these two classes of haplotypes are therefore sharply different ( and Figure S4). Demographic evidence against neutral evolution To distinguish further whether the very high H56 frequency is the outcome of positive selection or demographic effects, coalescence-based simulations were performed. The null hypothesis that a haplotype carrying four or more D alleles could achieve a frequency equal to or higher than the observed H56 frequency in each of the AF, GE, US and JP populations under neutral evolution was tested ( Table S4). For this purpose, thirty-three different demographic models embodying population growth [21], population bottlenecks [21], [22], population substructure [21], population growth plus substructure [23], and structured ancestral population with subsequent bottlenecks and expansion [24], were employed. For the AF samples, this null hypothesis was rejected with the Garrigan and Hammers' low-migration model ( P= 0.00380–0.00420) and Voight's models with most severe bottleneck ( P= 0.00118–0.00052). As well, it was marginally rejected with the ancient population expansion model ( P= 0.06153), the extended growth core model with mild bottleneck ( P= 0.06780) and Voight's bottleneck with modest bottleneck ( P= 0.06143), although it could not be rejected with the other models. For all three non-AF populations the null hypothesis was rejected for all of the demographic models analyzed except for JP in the case of Model 10 incorporating the most severe bottleneck. These results provided compelling evidence for positive selection acting on H56. While any positive selection acting on the region surrounding Yi6AH151 would preclude a reliable dating of the SNPs in the region, the fact that the four high-D SNPs achieved high-D status in all four of the human populations examined () suggests that these high-D SNPs appeared before the divergence of the human populations. Coalescence-based dating was carried out for the four high-D SNPs based on two different mutation rates (see Methods). The mutation rate estimated from human-chimpanzee divergence based on a constant molecular clock [25] yielded age estimates for these SNPs ( Table S6A) far older than the generally accepted time of human speciation, further testifying to the process of positive selection acting on the region. On the other hand, an accelerated mutation rate equal to that of fast-evolving human mitochondrial DNA [26] yielded age estimates of 139.91±10.09 Kya for rs6556547, 113.31±18.35 Kya for rs187269, 92.82±19.06 Kya for rs1816071, and 69.44±20.14 Kya for rs1816072 in coalescence-based calculations with the Rho index [27] ( Table S6; ). These age estimates, within the time frame between the origin of the anatomically modern human around 150 Kya [28] and migrations out of Africa around 60 Kya [29], gave evidence to a fast rate of evolutionary change, driven by the positive selection, comparable to that of mitochondrial DNA. Population variations in allelic and haplotype frequencies Pronounced population variations were observed with respect to the frequencies of alleles ( and Table S1) and haplotypes ( and Table S3) among the Yi6AH151 SNPs. The D-allele frequency of the youngest high-D SNP rs1816072 was considerably lower in AF (31.2%) than in the three non-AF populations (57.1–63.9%). This was even more the case with H56, which displayed a frequency of 18.1% for AF compared to 53.4–63.6% for the three non-AF populations. These findings suggest that the accumulation of the D-alleles and HG-D began not long prior to the migrations of the non-AF populations from Africa approximately 60 Kya [30], and continued after the separation of the different populations. The evolutionary history of the region surrounding Yi6AH151 could be reconstructed from the male genotype frequencies from the AF and the three non-AF populations together with the Chinese cohort (CH) employed in the initial report on GABRB2-schizophrenia association [4] ( Table S5). In , the homozygous D-allele genotype (DD) frequencies of from left to right the oldest rs6556547, the second oldest rs187269, the third oldest rs1816071 and the youngest rs1816072 in the male control samples from these five populations are plotted in the order of AF-GE-US-JP-CH in accordance with the order of ascending DD frequencies for the three younger SNPs. This ascending order coincided largely with the order of genetic distances of these non-AF populations from AF, which placed the East Asia-Africa distances much greater than the Europe-Africa distances [31]. The similarity of the monotonic ascending DD-frequency gradients for the three younger SNPs is consistent with the identified positive selection being a recent and possibly ongoing process. Comparable DD frequency gradients were not demonstrated for the female samples which were more limited in sample size. The rs6556547 SNP did not exhibit a monotonic ascending DD-frequency gradient, owing at least in part to the high DD frequency of 66.7% ( Table S5) even in the AF population, which is keeping with the D-allele of this SNP being the oldest among the four high-D SNPs. In contrast to the controls, the 436 male schizophrenic samples did not conform to a monotonic ascending DD-genotype frequency gradient for any of the four high-D SNPs ( and Table S5). In fact, a modest monotonic descending gradient was displayed by rs1816072, and a flat-top descending gradient by rs6556547. The divergent behavior of the control and schizophrenic DD-frequencies becomes particularly pronounced in the schizophrenia/control plot, which yielded a monotonic descending gradient for all four high-D SNPs. It indicates a relationship between DD-frequencies and schizophrenia that diverges from that between DD-frequencies and the controls, in accord with the association of the SNPs in this genomic region with schizophrenia observed at the genotype level or haplotype level or both [4], [9]. ATP-dependences of receptors containing the two β2-isoforms Functionally, it has been demonstrated in a separate Caucasian cohort that the presence of the derived alleles of the three younger high-D SNPs rs187269, rs1816071 and rs1816072 in either homozygote or heterozygote forms significantly increased both the total β 2 mRNA expression of the combined alternatively-spliced long and short β 2 isoforms, and the long/short β 2 isoform ratio, relative to the homozygote forms of the ancestral alleles (the fourth high-D SNP rs6556547 was not included in the analysis) [12]. An increase in total β 2 subunit expression would enhance GABA A receptor functions and therefore the level of inhibitory transmissions in the CNS, the majority of which are mediated by β 2-containing GABA A receptors. On the other hand, an increase in the long/short β 2 isoform ratio would bring about a greater run-down of GABA A-mediated electrophysiological current upon repetitive GABA stimulation in the absence of externally added ATP [12]. The pivotal role of energy status in the current run-down induced by repetitive GABA stimulation was confirmed in the present study by the results in , where raising the intracellularly infused ATP from 1 mM to 4 mM was found to reduce the amplitude of the run-down. Since this reduction was much greater with the long β2 isoform (β2L)-containing receptors compared to the short β2 isoform (β2S)-containing receptors, the difference in current run-down between the two kinds of receptors became narrowed at 2 mM compared to 1 mM ATP, and practically eliminated at 4 mM ATP. Thus the long/short β2 isoform ratio was confirmed as an important determinant in the energy regulation of GABAA receptor function. Such energy regulation of GABAA receptor function could contribute for example to the well-known heightening of alertness by hunger in contrast to the relative lethargy induced by satiety: hunger cuts down ATP supply, thereby inducing GABA-current rundown and decreasing inhibitory CNS neurotransmissions mediated by long β2 isoform-containing GABAA receptors. It follows that enhancement of the long/short β2 isoform ratio by the derived alleles of the high-D SNPs would reduce such inhibitory CNS neurotransmissions under normal conditions, but much less so under conditions of energy deprivation. Within the schizophrenia-associated 3,551-bp region of human GABRB2, the human lineage displayed accelerated evolutionary adaptation. The high DD-frequencies of the oldest high-D SNP rs6556547 in the control samples, ranging between 70.5–87.1% for the five human populations ( Table S1 and Table 1 in [4]) signaled strong positive selection of the derived allele of this SNP over the ancestral allele found in the chimpanzee. For the three younger high-D SNPs rs187269, rs1816071 and rs1816072, the DD-frequencies were not as high, but the positive selections of derived over ancestral alleles were just as evident. These positive selections are striking in view of the low sequence divergence among primates in this region. They were shown to be statistically significant upon testing by stringent criteria ( Table S4), and found confirmation in the lower diversity of the haplotypes containing the D-allele of rs1816072 (, and Table S2). They might be facilitated by the human-specific Alu Yi6AH151 insertion in the region; insertions of this type are known to increase homologous recombinations and mutations, on which selection could act [32], [33]. The dissimilar enrichments of the derived alleles displayed by the different populations suggest that the positive selections of these alleles, especially the younger ones, are recent and likely ongoing. Based on the age estimates of the four derived alleles obtained using the mitochondrial DNA mutation rate as a proximate, the time-span of these selection processes overlapped with the time frame of Mellars' proposed history of modern human evolution [29], with the emergence of the four high-D SNPs broadly coinciding with human population expansion in, and dispersal from, Africa (). Since the four high-D SNPs occur in the intronic regions of GABRB2, the impact of their allelic status may be expected to be regulatory in nature. In keeping with this expectation, their derived alleles were found to increase total β 2-expression and to enhance inhibition of GABA A function upon ATP depletion [ [12]; ]. These two opposing effects of the derived alleles could be fundamental to the differences between populations. Because β 2-containing GABA A receptors mediate the majority of CNS inhibitory neurotransmissions, the derived alleles would increase the overall activities of CNS inhibition by increasing total β 2-expression. At the same time, however, they would also accentuate the inhibition of GABA A function under conditions of energy deprivation as occasioned by food shortages. Accordingly the strength of the positive derived-allele selections in any population would depend on the level of GABA A-mediated CNS inhibitions required by the population, as well as the historical pattern of famines and severe food shortages in the course of its evolution. Various environmental, social and other population-specific factors could affect the required level of GABA A-mediated CNS inhibitions. In baboons, negative modulation of GABA A receptor produced effects that varied with the social status of the subject [34]. Among humans as well, evidence suggests that social organization could influence behavior pertinent to survival and evolution [35], [36]. The distance of the migrations out-of-Africa, the size of the populations participating in these migrations, and impact of agriculture [37] are other determinants that could favor the evolution of dissimilar GABA A activity profiles in different populations. Consequently, the evolved frequencies of the derived alleles of the high-D SNPs can not be expected to be the same for different populations. The schizophrenia-relevance of the positive selection of the derived genotypes is suggested by the drastic differences between schizophrenia and control in their DD-frequency profiles (). The control samples showed an indefinite trend for the oldest high-D SNP, but an upward gradient for the three younger high-D SNPs, in the DD-frequency plots over the AF, GE, US, JP and CH populations, providing a useful evolutionary snapshot of the selection process. In contrast, an indefinite trend (rs187269 and rs1816071) or downward trend (rs6556547 and rs1816072) was observed over these five populations for the schizophrenic samples; the reasons for the two downward gradients yet remain to be understood, but it is not ruled out that assortative mating, which has been observed in schizophrenia [38], might be a contributing factor. The schizophrenia/control ratio in DD-frequency thus decreased monotonically for all four high-D SNPs over these five populations, clearly establishing that the positive selection manifested by the controls was substantially weakened among the schizophrenics. Although the ratio exceeded unity in the GE samples, was close to unity in the US samples, but less than unity in the JP and CH samples, the schizophrenic/control ratios for all four SNPs conformed to a similar descending gradient over the GE-US-JP-CH populations. This uniformity shown by the four high-D SNPs suggests that the nature of the difference between control and schizophrenic samples was basically comparable for the four individual high-D SNPs. An inhibition demand hypothesis may be proposed to address the biological basis of the overall positive selection of derived genotypes in GABRB2, and its potential significance to the etiology of schizophrenia and possibly also other psychiatric disorders involving GABAA. The proposal consists of: (a) a balance between CNS excitations and inhibitions is essential to mental health; (b) since there is only one inhibitory neurotransmitter, GABA, in contrast to several excitatory neurotransmitters in the brain, the GABAergic system is among the systems that are stringently subjected to evolutionary adjustment; (c) in general, human genetic evolution is slow relative to a rapidly changing environment that imposes increasing demand on CNS inhibitory functions; (d) the derived genotypes, which influence the regulation of the GABAergic system, tend to be reduced in schizophrenics; and (e) such and other alterations affecting the GABAergic system could contribute to schizophrenia etiology. While purifying selections are often encountered eliminating the rare, deleterious mutations responsible for mendelian diseases, positive selections of protective derived alleles are increasingly observed in common disorders. For example, there are indications of positive derived-allele selection in the AGT gene for angiotensinogen [39] and CYP3A5 gene for cytochrome P450 [40] protecting against hypertension, and similarly positive derived-allele selection in the CAPN10 gene for calpain 10 [41] and PPARgamma gene [42]– [44] protecting against type-II diabetes. These positive selections, consistent with the sodium-retention hypothesis for hypertension [45] and thrifty-gene hypothesis for diabetes [46], respectively, may be interpreted in terms of an ancestral-susceptibility model for common diseases [44] which proposes that, on account of shifts of environment and lifestyle from ancient to modern times, originally harmless or even beneficial ancestral alleles could enhance disease susceptibility in the modern populations, such that protective derived alleles providing improved adaptation to the altered circumstances are positively selected. In this regard, it is noteworthy that because common diseases are usually multigenic in nature, the divergence between modern and ancestral circumstances that is beneficially addressed by the protective derived alleles of a disease-susceptibility gene could arise not only from shifts of environment and lifestyle. It could also arise within the body from alterations in the allelic status of other interacting, co-evolving genes, causing the ancestral alleles to interact suboptimally with other genes in the modern population. For common diseases not expressly related to diet or lifestyle, such internal alterations in the genomic context of a susceptibility gene could be as important as, or even more important than, external shifts of environment and lifestyle. In conclusion, because of changes between ancient and modern populations with respect to the genomic context in which GABRB2 is embedded, and with respect to environment and lifestyle, the ancestral alleles of the high-D SNPs rs6556547, rs187269, rs1816071 and rs1816072 in GABRB2 have become functionally inadequate in the modern populations. This inadequacy has brought about recent and possibly ongoing positive selections for their cognate derived alleles. Because of the dissimilar evolutionary paths undergone by different human populations, each population has acquired through evolution its own optimized capacity of GABAergic receptors and response of these receptors to energy regulation, as determined by among other factors the derived alleles of the high-D SNPs. The occurrence of positive selection, observed for the first time for any schizophrenia susceptibility genes, in GABRB2 points to a fundamental role of GABAA function in schizophrenia etiology, as well as the potential usefulness of searching for positive selection among various susceptibility genes for schizophrenia and other complex disorders. Human subjects A total of 1,179 individuals (Female 345; Male 834), including 743 unrelated non-schizophrenia subjects (Female 345; Male 398) and 436 schizophrenic male patients but not including relatives in trios, from four different ethnic populations, African (AF), German Caucasians (GE), Caucasians of USA (US) and Japanese (JP) were studied. For the JP and GE samples, details of sample source and diagnostic procedure were described in Lo et al. [9]. In brief, the JP samples consisted of 207 unrelated control subjects (Female 105; Male 102) and 210 unrelated schizophrenia male patients. The GE samples consisted of 190 unrelated control subjects (Female 76; Male 114) and 119 unrelated male schizophrenics of systematic subtype. All schizophrenia patients were in-patients and fulfilled the diagnostic criteria for schizophrenia according to the fourth edition of Diagnostic and Statistical Manual of Mental Disorders [47]. The GE patients belonged to the systematic schizophrenia subtype, the most severe form of schizophrenia, on the basis of Leonhard's classification of endogenous psychoses [48]. Written informed consent was obtained from each subject. Approval for the study was obtained from the ethnical committees of Kurume University for the JP samples and of University of Würzburg for the GE samples. A total of 370 US samples consisted of 263 unrelated control subjects (Female 127; Male 136) and 107 schizophrenia male patients. Recruitment of the samples was as described [49]. Briefly, the patients were evaluated using the semi-structured diagnostic interview scale called the Diagnostic Interview for Genetic Studies [50]. This information was combined with medical records and available information from relatives. Consensus diagnoses were made using DMS-IV criteria. The controls were drawn unscreened from neonates from a local hospital without any demographic details apart from gender and reported maternal ethnicity. The study was approved by the University of Pittsburgh Institutional Review Board. Written informed consent was obtained from all participants except for the neonate controls in accordance with IRB guidelines. For the AF population, DNA samples of 25 unrelated individuals and 30 parent-offspring trios were obtained from Coriell Cell Repositories (Camden, NJ). The 25 unrelated individuals (Female 9; Male 16) included eight from North of Sahara (Female 2; Male 6; Panel ID HD12), seven from South of Sahara (Female 2; Male 5; Panel ID: HD11), five Biaka African-Pygmy from Bagandu in the Central African Republic (Female 3, Male 2; Repository Number NA10469–NA10473), and five Mbuti African-Pygmy from Ituri Forest in northeast Zaire (Female 2; Male 3; Repository Number NA10492–NA10496). All members of each of the 30 parent-offspring trios from Yoruba in Ibadan, Nigeria (Female offspring 7; Male offspring 23; Panel ID: HAPMAPPT03) were genotyped and yielded successful genotyping percentage greater than 90% except for two mother samples (Repository Numbers GM19209 and GM19099), which accordingly were not included in present study. The accuracy in phase estimation of haplotypes for parents was confirmed by genotype data from the offspring. Only data of unrelated parents (Mother 28; Father 30) were used in the statistical analysis. Genomic DNA of non-human primates Non-human primate genomic DNA samples obtained from Coriell Cell Repositories (Camden, NJ) included (with Coriell Repository Numbers): Macaca arctoides (stumptail macaque, NA03443), Macaca nemestrina (pigtailed macaque, NG07921), Macaca nigra (celebes crested macaque, NG07101), Macaca fascicularis (crab-eating macaque, NA03446) and Erythrocebus patas (patas monkey, NG06254). Polymerase chain reaction and sequencing To fully sequence the 3,551 base pairs (bp) genomic region flanked by the two schizophrenia-associated SNPs rs6556547 and rs187269 in GABRB2 [4], [9], a 7.4-Kb genomic region starting from 2,148 bp upstream of Exon 9 to 519 bp downstream of Exon 10 was generated by polymerase chain reaction (PCR) and served as first PCR template for amplification of two nested-PCR products. List of potential primers for PCR and resequencing were designed using the Primer 3 program [51]. The sequences of primers, designed based on chromosome 5 contig NT_023133.12, are listed in Table S7. Specificity of each potential primer was checked with BLASTN, an alignment tool of the National Center for Biotechnology Information ( www.ncbi.nlm.nih.gov/BLAST/). Only specific pairs of primers, with less than 5 hits to the human genome and none of them in GABA A receptor genes other than GABRB2, were accepted. Together with the relatively long length (7.4 Kb) of the first PCR product and the employment of nested-PCR, this level of primer specificity reduced the probability of amplifying paralogous sequences in the genome. PCR amplification of the 7.4-Kb region was performed in a 20 µl mixture containing 70 ng of genomic DNA, 2 µl of 10× PCR buffer for KOD Hot-Start DNA Polymerase, 20 µM of each dNTP, 0.4 mM of MgSO 4, 0.12 µM of each primer and 0.5 U of KOD Hot-Start DNA Polymerase (Novagen, Madison WI). PCR conditions were optimized using gradient PCR to ensure homogeneity of the amplified products. PCR consisted of initial polymerase activation at 95°C for 3 min, followed by 36 cycles each of 30 sec at 95°C, 30 sec at 62°C and 5 min and 30 sec at 68°C, and a final extension step at 68°C for 5 min and 30 sec. Post-PCR product was immediately purified by ethanol precipitation and recovered in 1× Tris-Cl (USB, Cleveland, Ohio) and ethylene-diamine-tetra-acetic acid (EDTA) (Invitrogen Corporation, Grand Island, NY) buffer, as described in Lo et al. [4]. Two nested-PCR fragments, one from 2,148 bp upstream to 498 bp downstream (fragment A), and the other from 342 bp upstream to 2,039 bp downstream (fragment B), of exon 9 were amplified using the 7.4-Kb purified PCR product as template. Each nested PCR reaction contained 0.6 µl of the 7.4-Kb purified PCR product, 75 nM of each primer, 50 nM of each dNTP, 2.5 mM of MgCl2 and 1 U of Taq DNA polymerase (Amersham Bioscience, Uppsala, Sweden) in a final volume of 20 µl. The nested-PCR reaction consisted of an initial denaturation at 94°C for 2 min, followed by 35 cycles each of 30 sec at 95°C, 30 sec at 58°C, 90 sec at 72°C, plus a final extension step at 72°C for 5 min. After nested PCR, the product in each instance was resolved on 1.2% agarose gel, stained with 0.5 µg/ml of ethidium bromide, and examined under UV to confirm the presence of PCR product of expected size and absence of non-specific products. The stringency of nested-PCR amplification exceeded that for normal PCR, further eliminating non-specific products. The nested-PCR products were purified and recovered as for the first PCR product. SNP discovery and genotyping Both SNP discovery and genotyping were carried out by resequencing the nested-PCR products. For each of the nested PCR Fragment A and B, four sequencing primers were employed ( Table S7). Each sequencing reaction contained 3 µl of sequencing buffer, 0.5 µl of BigBye® Terminator version 3.1 (Applied Biosystems Inc., Foster City, California), ~100 ng purified nested PCR products and 1 mM sequencing primer. Each cycle of sequencing reaction consisted of initial denaturation at 96°C for 1 min, followed by 25 cycles each of 10 s at 96°C, 5 s at 50°C, and 4 min at 60°C. Ethanol precipitation was used to clean-up the post-sequencing products as for the PCR products. Each air-dried sequencing sample was dissolved in 10 µl Hi-Deionized Formamide (Applied Biosystems Inc., Foster City, California), denatured at 95°C for 1 min and immediately held at 4°C prior to sequencing with a Model 3100 Genetic Analyzer (Applied Biosystems Inc., Foster City, California). Sequence chromatogram alignment-based SNP discovery and genotype calling were carried out using the software package PolyPhred version 4.2 [52]. All genotyping results were manually confirmed by at least two independent researchers. All analyzed SNPs were located within the high-quality region (Quality Value ≥20), and occasional low-quality passes were re-sequenced. Inference of haplotype phase Inference of haplotypes from the genotype data was performed using PHASE version 2.1 as described [53]. The haplotype phases of both parents in AF and US family-trios were estimated based on the genotype data of the corresponding offspring using the P1 option of the program. The inferred haplotypes of AF and US parents were used as phase-known samples in the haplotype phase estimation of population-based genotype data in order to increase the accuracy of haplotype reconstruction. Input of genotype data of unrelated individuals was then placed into the program to infer haplotype phase under the default settings for five independent runs, except that the final iteration was carried out with a 10-fold longer running time. Thus the inferred haplotypes were obtained from five independent runs giving the best average goodness of fit. Construction of hypothetical human ancestral sequence Alignment of human and non-human primate sequences for a ~1.8-Kb region upstream of Exon 9 of GABRB2 was performed using ClustalW [54]. This revealed a human-specific Alu insertion in Intron 8 of GABRB2. Similarity between sequences was visualized using VISTA [55]. To characterize the sub-family identity of the human-specific Alu insertion in Intron 8 of GABRB2, its sequence was searched against the repetitive elements library RepBase using the program RepeatMasker [56]. Consensus sequences of Alu subfamilies and the sequence of the inserted Alu were aligned using ClustalW [54]. To obtain the consensus phylogenetic tree, the SEQBOOT, DNAPARS and CONSENSE programs in the PHYLIP software package [57] were employed. The consensus phylogenetic tree was displayed using TreeView version 1.6.6 [58]. The hypothetical human ancestral sequence of the 3,551-bp region of GABRB2 was constructed in two stages. For SNPs on the sequences flanking the human-specific Yi6AH151, chimpanzee sequences were used as outgroup to infer their ancestral alleles. For SNPs within Yi6AH151, consensus sequence of the Alu Yi6 subfamily was used for this purpose. Summary statistics of mutation parameters The Hudson, Kreitman and Aguadé's test [18] is based on the neutral molecular evolution expectation that DNA sequence polymorphism within a species and DNA sequence divergence between species, will be proportional to the neutral mutation rate [59]. By comparing the number of nucleotide differences between and within species for the 3,551-bp region against the genome average estimates using DnaSP, the rate of evolution in this region could be tested for departure from neutrality. DNA diversity level among human sequences was measured using the program DnaSP to yield four mutation parameters: haplotype diversity Hd [60] equivalent to gene heterozygosity, nucleotide diversity π [61] measuring the average number of pairwise differences, Watterson's θ- W [62] based on the number of segregating sites, and θ- H [63] weighting the presence of high-frequency derived variants. Under the standard neutral model of a random-mating population of constant size [59], these genetic mutation parameters would each approach θ = 4 Neµ, where Ne is the diploid long-term inbreeding effective population size and µ is the mutation rate per generation. The four summary statistics Tajima's D [64], Fu and Li's D and F [65] and Fay and Wu's H [63] were evaluated regarding the site-frequency spectrum for or against an assumption of neutrality. Departures from the neutral model are usually attributed to selective or demographic effects. The Tajima's D test compares θ- W to π. The Fu and Li's D and F tests compare θ- W and π respectively to the number of derived unique mutations, which represent the mutations on external branches of the tree. The Fay and Wu's H test compares π to θ- H, and is sensitive for detecting an excess of high-frequency-derived alleles, from a hitchhiking effect under positive directional selection. For the Fu and Li's D and F and Fay and Wu's H tests, an outgroup sequence is required to define the ancestral status of alleles. The hypothetical human ancestral sequence was used as the outgroup sequence. The significance of any difference in Fay and Wu's H value between HG-N and HG-D was tested with 105 permutations. In each permutation, the N and D alleles of SNP rs1816072 were randomly exchanged between the two groups of haplotypes, and absolute differences in Fay and Wu's H value were calculated between the two groups. The number of permutations out of the total of 105 permutations yielding a greater difference in value between HG-N and HG-D were counted to give the probability value P. Coalescence-based neutrality test with demographic models The simulation method based on the coalescence process was employed using the mksample program [66]. For each human population, the observed number of chromosomes and segregating sites were specified to generate 10 5 simulation datasets to test the significance of Fay and Wu's H and Tajima's D values and the probability of positive selection of the major haplotype for each of the demographic models. Recombination rate and gene conversion were stringently set at the 10 −8 per generation close to the genome average, and an average tract length of 100 bp, respectively, to minimize type I error. The significance of Fay and Wu's H and Tajima's D values in each population was calculated using simulations of various demographic models under the assumption of neutral evolution. For each population, the number of simulation datasets showing Fay and Wu's H or Tajima's D values smaller than the observed D or H values was counted. On the other hand, in order to access the statistical probability of a history of positive selection at the major haplotype H56 in human populations, a null hypothesis of observing a haplotype containing four derived alleles having the same or a higher frequency than the observed frequency of H56 in neutral evolution with various demographic histories was tested. A total of thirty-three demographic models, namely M1 to M33 were examined. The models of M1 to M9 embodied the effects of population growth and substructure as described by Evans et al. [21]. M10 to M25 were models with population growth and substructure based on Currat et al. [23]. M25 to M29 were population bottleneck models based on the demographic analysis of multiloci data by Voight et al. [22]. M30 to M33 were the low-migration models as described by Garrigan and Hammers [24]. The parameters for Evans' models [21] M1 to M9 were as follows: M1, a constant effective population size of 10 4; M2, exponential population expansion since 5,000 generations ago from an initial population size of 10 4 to a present population size of 10 7; M3, exponential population expansion since 1,000 generations ago from an initial population size of 10 4 to a present population size of 10 7; M4, a severe bottleneck starting 5,000 generations ago reduced the population size instantly from 10 4 to 10 3, which remained constant until 2,500 generations ago, when the population expanded exponentially to a present size of 10 7; M5, five consecutive bottleneck events started at 7,000 generations ago, in each instance reducing the population size from 10 4 instantly to 10 3, following by constant size for 500 generations and subsequent recovery by exponential growth back to 10 4 in the ensuing 500 generations; starting at the end of the fifth bottleneck at 2,500 generations ago, the population expanded exponentially to a present size of 10 7; M6 to M9, having a population structure where the total number of chromosomes for each human population was split equally into two to five subpopulations, with 1 migration per generation between any two populations under constant population size condition. In Currat's models [23], a subpopulation split off from a core population at 1,000 generations before the present, and grew exponentially from an initial effective population size ( ns) to the present size of 10 7 individuals. For each model, a range of ns from 10 to 10 4 was tested. For the stable core models M10 to M13 among them, the effective population size of the core population remained constant at 10 5; bottleneck severities ranged from 0.0001 for ns= 10 to 0.1 for ns= 10 4. For the growing core models M14 to M17, the population core grew from an initial size of 10 4 individuals at 1,000 generations ago to 10 7 at present. For the extended growing core models M18 to M21, the core population grew from 10 4 individuals at 5,000 generations ago to the present 10 7. For the early fission models M22 to M25, a subpopulation split from a core population of ns at 5,000 generations ago and remained constant in size until 1,000 generations ago, and grew thereafter to the present 10 7, while the core population grew from 10 4 individuals at 5,000 generations ago to the present 10 7. M26 to M29 were population-bottleneck models based on Voight et al. [22]. For all of these four models, a bottleneck event occurred at 1,600 generations ago (t start), when an ancestral population (N A) of 10 4 was reduced to a size of 10 3 for M26 (bottleneck severity, b= 0.1), 4×10 3 for M27 ( b= 0.4), and 50 for both M28 and M29 ( b= 0.005). After a period of t dur, the population grew exponentially back to its original size of 10 4. The t dur was 400 generations for M26, zero for M27, 600 for M28, and 300 for M29. The low-migration models M30 to M33, based on Garrigan and Hammers [24], described a structured ancestral population of 2,000 chromosomes, which admixed with two other demes of the same size at a low-migration rate (4Nm = 0.5) 32,000 generations ago (800 Kya); a bottleneck event occurred at 1,600 generations ago as described in M26 to M29, except that the population size recovered to 20,000 chromosomes. Estimation of SNP coalescence age Two established mutation-based methods were employed to estimate the coalescence age of SNP: a) using the molecular clock derived from the divergence between human and chimpanzee to determine the time to the Most Recent Common Ancestor MRCA [25]; and b) using the Rho (ρ) index to define the age in unit of mutation from MRCA to the descendent haplotypes of SNPs [27], and the mutation rate of human mitochondria DNA (mtDNA) [26] to obtain the estimated coalescence age of SNPs. Both approaches were suggested to be unbiased by demographic history [25], [27]. In the first method, the SNP age was estimated by the mutation-based method of Thomson et al. [25]. Average number of mutations per base in lineages from the MRCA to haplotypes carrying the D allele of SNP ( d) for each human population was calculated using the DnaSP version 4.10 [67]. By comparing human and chimpanzee sequences in this region, the human-chimpanzee nucleotide divergence ( D) in the region was estimated for human populations in mutations per base. Assuming a human-chimpanzee divergence time ( Tsplit) of 6 Mya, the estimated mutation rate per site per year (μ) was obtained by the formula μ = D/( 2*Tsplit). The time to MRCA (TMRCA) in years was obtained by the formula TMRCA = d*μ. In the second method, the age of haplotypes carrying derived alleles of SNPs in terms of the number of mutations was measured by the Rho (ρ) index [27] by means of the program NETWORK version 4.2 (NETWORK website). A phylogenetic tree of inferred haplotypes was constructed using the median-joining method [68]. By defining a root node, i.e. the hypothetical human ancestral haplotype, ρ between the root node and a descendent haplotype or a group of descendent haplotypes, i.e. a haplotype group, was calculated. The ρ statistic represents the average number of mutational changes between the root node and an individual haplotype within the phylogeny relating the intra-allelic diversity of the root node and the haplotypes of interest. Relationship between ρ and TMRCA ( t) is given by the equation, ρ = μ t where μ is the mutation rate per site per year. To estimate the TMRCA, the mutation rate μ for human mtDNA, which is equal to 1 mutation per 20,180 years [26], was employed for converting ρ to t. The age of a descendent haplotype is the same as the minimum age estimate for the preceding mutation. Expression and electrophysiology of recombinant GABAA receptors Human embryonic kidney (HEK293) cells were transiently co-transfected with pcDNA3.1-α 1, pcDNA3.1-γ 2L plus either pcDNA3.1-β 2S or pcDNA3.1-β 2L, using the Genejuice transfection reagent (Novagen) as described [12]. Whole-cell patch clamp recordings were carried out on the cells using an EPC9 amplifier (HEKA, Germany) at 36 to 60 hours after transfection. Cells were voltage-clamped at −60 mV. Pipette-to-bath resistance was 3.0–6.0 MΩ when filled with the internal solution containing 140 mM of CsCl, 1 mM of MgCl 2, 11 mM of EGTA, 10 mM of HEPES, and 1, 2 or 4 mM of Mg ++-ATP, adjusted to pH 7.3 with CsOH. The external superfusion solution contained 150 mM of NaCl, 3 mM of KCl, 1 mM of MgCl 2, 1 mM of CaCl 2 and 10 mM of HEPES, adjusted to pH 7.2 with NaOH [69]. The cells were constantly perfused with the external solution at 5 ml/min. Repetitive applications of GABA (100 or 300 µM, 5-s duration, 60-s interval) to induce current rundown was initiated when the cells were found to display consistent responses to low concentration of GABA (10 µM, 3-min interval) [70]. Thirty consecutive whole-cell responses to the repetitive applications were evaluated in terms of the observed peak current as percentile initial peak current. The results obtained from 7–10 cells collected from 6 independent transfections were presented in mean±standard error. Two-tailed Student's t-test was employed for calculation of statistical differences between receptors containing β 2L and those containing β 2S. Table S1 All twenty-nine SNPs identified from unrelated non-schizophrenic individuals of four different populations. (0.03 MB XLS) Table S2 Summary statistics of mutation frequency spectrum for haplotype-groups of rs1816072 in different populations. (0.02 MB XLS) Table S3 Compositions and population frequencies of 75 inferred haplotypes. (0.06 MB XLS) Table S4 Coalescence-based neutrality test of various demographic models. (0.04 MB XLS) Table S5 Population frequencies and frequency ratio of the four high-D SNPs in male controls and schizophrenics. (0.02 MB XLS) Table S6 Estimated coalescence age of the four high-D SNPs by mutation-based methods. (0.03 MB XLS) Table S7 Primers for PCR and sequencing of the 3,551-bp GABRB2 fragment. (0.02 MB XLS) Figure S1 Sequence similarity between human and 7 non-human primates displayed by VISTA [55]. The sequences of chimpanzee and rhesus were obtained from the NCBI database. The DNA of the five other non-human primates were sequenced over this 1.8 Kb region in GABRB2. (0.82 MB TIF) Figure S2 An unrooted phylogenetic tree of Alu sequences. (A) The tree was generated from an alignment of the consensus sequences of Alu sub-families and the Yi6AH151 using DNAPARS in the PHYLIP software package [57]. The consensus tree generated from 1,000 replications is labeled with bootstrap values at the nodes and displayed with TreeView [58]. The clade containing human-specific Alu Yi6AH151 and its closest neighbor Alu Yi6 is highlighted in grey. (B) Sequence alignment of Alu Yi6 consensus sequence and Yi6AH151. Refer to Salem et al. [14] for the sequences of all 150 members of Yi6 subfamily. (0.98 MB TIF) Figure S3 Plot of estimated recombination rate and location of recombination hotspots in GABRB2. The plot is adapted from Genome Browser ( http://genome.ucsc.edu/cgi-bin/hgGateway) report, which employed the HapMap Phase II data. The red box indicates the region of GABRB2 studied. (0.75 MB TIF) Figure S4 Summary statistics for all HG-N and HG-D haplotypes. Tajima's D and Fu and Li's D values are plotted for AF, GE, US and JP. (0.97 MB TIF) We are grateful to Professor J. Tze-Fei Wong for critical review of the manuscript and Miss Peggy Lee for technical support. We would like to acknowledge Hewlett-Packard for the DL580 server used in this project. The authors declare that there are no competing financial interests. 1. Gottesman II. Vital statistics, demography, and schizophrenia: editor's introduction. Schizophr Bull. 1989;15:5–7. [PubMed] 2. Austin J. Schizophrenia: an update and review. J Genet Couns. 2005;14:329–340. [PubMed] 3. Harrison PJ, Weinberger DR. Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence. Mol Psychiatry. 2005;10:40–68. [PubMed] 4. Lo WS, Lau CF, Xuan Z, Chan CF, Feng GY, et al. Association of SNPs and haplotypes in GABAA receptor β2 gene with schizophrenia. Mol Psychiatry. 2004;9:603–608. [PubMed] 5. Korpi ER, Sinkkonen ST. GABAA receptor subtypes as targets for neuropsychiatric drug development. Pharmacology & Therapeutics. 2006;109:12–32. [PubMed] 6. Liu J, Shi Y, Tang W, Guo T, Li D, et al. Positive association of the human GABAA receptor β2 subunit gene haplotype with schizophrenia in the Chinese Han population. Biochem Biophys Res Commun. 2005;334:817–823. [PubMed] 7. Petryshen TL, Middleton FA, Tahl AR, Rockwell GN, Purcell S, et al. Genetic investigation of chromosome 5q GABAA receptor subunit genes in schizophrenia. Mol Psychiatry. 2005;10:1074–88, 1057. [PubMed] 8. Yu Z, Chen J, Shi H, Stoëber G, Tsang SY, et al. Analysis of GABRB2 association with schizophrenia in German population with DNA sequencing and one-label extension method for SNP genotyping. Clin Biochem. 2006;39:210–218. [PubMed] 9. Lo WS, Harano M, Gawlik M, Yu Z, Chen J, et al. GABRB2 association with schizophrenia: commonalities and differences between ethnic groups and clinical subtypes. Biol Psychiatry. 2007;61:653–660. [PubMed] 10. Ikeda M, Iwata N, Suzuki T, Kitajima T, Yamanouchi Y, et al. Association analysis of chromosome 5 GABAA receptor cluster in Japanese schizophrenia patients. Biol Psychiatry. 2005;58:440–445. [PubMed] 11. Jamra RA, Becker T, Klopp N, Dahdouh F, Schulze TG, et al. No evidence for an association between variants at the GABAA receptor β2 locus and schizophrenia. Psychiatr Genet. 2007;17:43–45. [PubMed] 12. Zhao C, Xu Z, Chen J, Yu Z, Tong KL, et al. Two isoforms of GABAA receptor β2 subunit with different electrophysiological properties: differential expression and genotypical correlations in schizophrenia. Mol Psychiatry. 2006;11:1092–1105. [PubMed] 13. Deininger PL, Batzer MA. Mammalian retroelements. Genome Res. 2002;12:1455–1465. [PubMed] 14. Salem AH, Kilroy GE, Watkins WS, Jorde LB, Batzer MA. Recently integrated Alu elements and human genomic diversity. Mol Biol Evol. 2003;20:1349–1361. [PubMed] 15. Deininger PL, Batzer MA. Alu repeats and human disease. Mol Genet Metab. 1999;67:183–193. [PubMed] 16. Venter JC, Adams MD, Myers EW, Li PW, Mural RJ, et al. The sequence of the human genome. Science. 2001;291:1304–1351. [PubMed] 17. The Chimpanzee Sequencing and Analysis Consortium. Initial sequence of the chimpanzee genome and comparison with the human genome. Nature. 2005;437:69–87. [PubMed] 18. Hudson RR, Kreitman M, Aguade M. A test of neutral molecular evolution based on nucleotide data. Genetics. 1987;116:153–159. [PubMed] 19. Bird CP, Stranger BE, Dermitzakis ET. Functional variation and evolution of non-coding DNA. Curr Opin Genet Dev. 2006;16:559–564. [PubMed] 20. Drake JA, Bird C, Nemesh J, Thomas DJ, Newton-Cheh C, et al. Conserved noncoding sequences are selectively constrained and not mutation cold spots. Nat Genet. 2006;38:223–227. [PubMed] 21. Evans PD, Gilbert SL, Mekel-Bobrov N, Vallender EJ, Anderson JR, et al. Microcephalin, a gene regulating brain size, continues to evolve adaptively in humans. Science. 2005;309:1717–1720. [PubMed] 22. Voight BF, Adams AM, Frisse LA, Qian Y, Hudson RR, et al. Interrogating multiple aspects of variation in a full resequencing data set to infer human population size changes. Proc Natl Acad Sci USA. 2005;102:18508–18513. [PubMed] 23. Currat M, Excoffier L, Maddison W, Otto SP, Ray N, et al. Comment on “Ongoing adaptive evolution of ASPM, a brain size determinant in Homo sapiens” and “Microcephalin, a gene regulating brain size, continues to evolve adaptively in humans”. Science. 2006;313:172. [PubMed] 24. Garrigan D, Hammer MF. Reconstructing human origins in the genomic era. Nat Rev Genet. 2006;7:669–680. [PubMed] 25. Thomson R, Pritchard JK, Shen P, Oefner PJ, Feldman MW. Recent common ancestry of human Y chromosomes: evidence from DNA sequence data. Proc Natl Acad Sci USA. 2000;97:7360–7365. [PubMed] 26. Saillard J, Forster P, Lynnerup N, Bandelt HJ, Norby S. mtDNA variation among Greenland Eskimos: the edge of the Beringian expansion. Am J Hum Genet. 2000;67:718–726. [PubMed] 27. Forster P, Harding R, Torroni A, Bandelt HJ. Origin and evolution of Native American mtDNA variation: a reappraisal. Am J Hum Genet. 1996;59:935–945. [PubMed] 28. White TD, Asfaw B, DeGusta D, Gilbert H, Richards GD, et al. Pleistocene Homo sapiens from Middle Awash, Ethiopia. Nature. 2003;423:742–747. [PubMed] 29. Mellars P. Why did modern human populations disperse from Africa ca. 60,000 years ago? A new model. Proc Natl Acad Sci USA. 2006;103:9381–9386. [PubMed] 30. Forster P. Ice Ages and the mitochondrial DNA chronology of human dispersals: a review. Philos Trans R Soc Lond B Biol Sci. 2004;359:255–264. [PubMed] 31. Rosenberg NA, Pritchard JK, Weber JL, Cann HM, Kidd KK, et al. Genetic structure of human populations. Science. 2002;298:2381–2385. [PubMed] 32. Batzer MA, Deininger PL. Alu repeats and human genomic diversity. Nat Rev Genet. 2002;3:370–379. [PubMed] 33. Otto SP, Barton NH. The evolution of recombination: removing the limits to natural selection. Genetics. 1997;147:879–906. [PubMed] 34. Sapolsky RM, Share LJ. A pacific culture among wild baboons: its emergence and transmission. PLoS Biol. 2004;2:E106. [PubMed] 35. Pike IL, Williams SR. Incorporating psychosocial health into biocultural models: preliminary findings from Turkana women of Kenya. Am J Hum Biol. 2006;18:729–740. [PubMed] 36. Sapolsky RM. The influence of social hierarchy on primate health. Science. 2005;308:648–652. [PubMed] 37. Cohen MN, Armelagos GJ. Paleopathology at the Origins of Agriculture. Orlando, Florida: Academic Press; 1984. Paleopathology at the Origins of Agriculture: Editor's Summation. pp. 585–601. 38. Parnas J. Assortative mating in schizophrenia: results from the Copenhagen High-Risk Study. Psychiatry. 1988;51:58–64. [PubMed] 39. Nakajima T, Wooding S, Sakagami T, Emi M, Tokunaga K, et al. Natural selection and population history in the human angiotensinogen gene (AGT): 736 complete AGT sequences in chromosomes from around the world. Am J Hum Genet. 2004;74:898–916. [PubMed] 40. Thompson EE, Kuttab-Boulos H, Witonsky D, Yang L, Roe BA, et al. CYP3A variation and the evolution of salt-sensitivity variants. Am J Hum Genet. 2004;75:1059–1069. [PubMed] 41. Vander MJ, Frisse LM, Fullerton SM, Qian Y, Del Bosque-Plata L, et al. Population genetics of CAPN10 and GPR35: implications for the evolution of type-II diabetes variants. Am J Hum Genet. 2005;76:548–560. [PubMed] 42. Altshuler D, Hirschhorn JN, Klannemark M, Lindgren CM, Vohl MC, et al. The common PPARgamma Pro12Ala polymorphism is associated with decreased risk of type-II diabetes. Nat Genet. 2000;26:76–80. [PubMed] 43. Deeb SS, Fajas L, Nemoto M, Pihlajamaki J, Mykkanen L, et al. A Pro12Ala substitution in PPARgamma2 associated with decreased receptor activity, lower body mass index and improved insulin sensitivity. Nat Genet. 1998;20:284–287. [PubMed] 44. Di Rienzo A, Hudson RR. An evolutionary framework for common diseases: the ancestral-susceptibility model. Trends Genet. 2005;21:596–601. [PubMed] 45. Gleibermann L. Blood pressure and dietary salt in human populations. Ecol Food Nutr. 1973;2:143–156. 46. Neel JV. Diabetes mellitus: a “thrifty” genotype rendered detrimental by “progress”? Am J Hum Genet. 1962;14:353–362. [PubMed] 47. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorder, the fourth edition. Washington, DC: American Psychiatric Press; 1994. 48. Leonhard K. Classification of Endogenous Psychoses and their Differentiated Etiology. New York: Springer; 1999. 49. Chowdari KV, Mirnics K, Semwal P, Wood J, Lawrence E, et al. Association and linkage analyses of RGS4 polymorphisms in schizophrenia. Hum Mol Genet. 2002;11:1373–1380. [PubMed] 50. Nurnberger JI, Jr, Blehar MC, Kaufmann CA, York-Cooler C, Simpson SG, et al. Diagnostic interview for genetic studies. Rationale, unique features, and training. NIMH Genetics Initiative. Arch Gen Psychiatry. 1994;51:849–859. [PubMed] 51. Rozen S, Skaletsky H. Bioinformatics Methods and Protocols: Methods in Molecular Biology. In: Krawetz S, Misener S, editors. Primer3 on the WWW for general users and for biologist programmers. Totowa, NJ: Humana Press; 2000. pp. 365–386. 52. Nickerson DA, Tobe VO, Taylor SL. PolyPhred: automating the detection and genotyping of single nucleotide substitutions using fluorescence-based resequencing. Nucleic Acids Res. 1997;25:2745–2751. [PubMed] 53. Stephens M, Smith NJ, Donnelly P. A new statistical method for haplotype reconstruction from population data. Am J Hum Genet. 2001;68:978–989. [PubMed] 54. Chenna R, Sugawara H, Koike T, Lopez R, Gibson TJ, et al. Multiple sequence alignment with the Clustal series of programs. Nucleic Acids Res. 2003;31:3497–3500. [PubMed] 55. Mayor C, Brudno M, Schwartz JR, Poliakov A, Rubin EM, et al. VISTA: visualizing global DNA sequence alignments of arbitrary length. Bioinformatics. 2000;16:1046–1047. [PubMed] 58. Page R. TREEVIEW: An application to display phylogenetic trees on personal computers. Computer Applications in the Biosciences. 1996;12:357–358. [PubMed] 59. Kimura M. The Neutral Theory of Molecular Evolution. Cambridge: Cambridge University Press; 1983. 60. Nei M, Tajima F. Maximum likelihood estimation of the number of nucleotide substitutions from restriction sites data. Genetics. 1983;105:207–217. [PubMed] 61. Nei M, Li WH. Mathematical model for studying genetic variation in terms of restriction endonucleases. Proc Natl Acad Sci USA. 1979;76:5269–5273. [PubMed] 62. Watterson GA. On the number of segregating sites in genetical models without recombination. Theor Popul Biol. 1975;7:256–276. [PubMed] 63. Fay JC, Wu CI. Hitchhiking under positive Darwinian selection. Genetics. 2000;155:1405–1413. [PubMed] 64. Tajima F. Statistical method for testing the neutral mutation hypothesis by DNA polymorphism. Genetics. 1989;123:585–595. [PubMed] 65. Fu YX, Li WH. Statistical Tests of Neutrality of Mutations. Genetics. 1993;133:693–709. [PubMed] 66. Hudson RR. Generating samples under a Wright-Fisher neutral model of genetic variation. Bioinformatics. 2002;18:337–338. [PubMed] 67. Rozas J, Sanchez-DelBarrio JC, Messeguer X, Rozas R. DnaSP, DNA polymorphism analyses by the coalescent and other methods. Bioinformatics. 2003;19:2496–2497. [PubMed] 68. Bandelt HJ, Forster P, Rohl A. Median-joining networks for inferring intraspecific phylogenies. Mol Biol Evol. 1999;16:37–48. [PubMed] 69. Greenfield LJ, Jr, Zaman SH, Sutherland ML, Lummis SC, Niemeyer MI, et al. Mutation of the GABAA receptor M1 transmembrane proline increases GABA affinity and reduces barbiturate enhancement. Neuropharmacology. 2002;42:502–521. [PubMed] 70. Huang RQ, Dillon GH. Maintenance of recombinant type A γ-aminobutyric acid receptor function: role of protein tyrosine phosphorylation and calcineurin. J Pharmacol Exp Ther. 1998;286:243–255. [PubMed]
|
This article has been 
